ILUMY

ilumy-logo

ILUMY is a digital design and prototyping firm that creates websites, apps and platforms.

#SimilarOrganizations #Website #More

ILUMY

Social Links:

Industry:
Apps Information Technology Web Development

Founded:
2002-01-01

Address:
Amsterdam, Noord-Holland, The Netherlands

Country:
The Netherlands

Website Url:
http://www.ilumy.com

Total Employee:
11+

Status:
Active

Contact:
31 20 7740033

Email Addresses:
[email protected]

Technology used in webpage:
LetsEncrypt Google Tag Manager Font Awesome Domain Not Resolving Global Site Tag Google Maps Cloudflare JS CDN JS PHP 7 Google Maps API


Similar Organizations

i-logics-logo

I-logics

I-logics is a digital web agency that specializes in websites and the development of online applications.

pibit-logo

Pibit

Pibit is a software and consulting firm that specializes in websites, apps, data science and voice automation.

Official Site Inspections

http://www.ilumy.com Semrush global rank: 9.82 M Semrush visits lastest month: 99

  • Host name: 136-144-168-253.colo.transip.net
  • IP address: 136.144.168.253
  • Location: Eindhoven Netherlands
  • Latitude: 51.4513
  • Longitude: 5.4009
  • Timezone: Europe/Amsterdam
  • Postal: 5657

Loading ...

More informations about "ILUMY"

Welcome | ILUMYA®

ILUMYA® is a prescription medicine used to treat adults with moderate to severe plaque psoriasis who may benefit from taking injections, pills (systemic therapy), or phototherapy (treatment โ€ฆSee details»

Plaque Psoriasis Treatment | ILUMYA® (tildrakizumab-asmn)

Learn about ILUMYA® (tildrakizumab-asmn), an IL-23 inhibitor injection indicated for adult patients with moderate-to-severe plaque psoriasis (PsO).See details»

Starting ILUMYA® Treatment | ILUMYA® (tildrakizumab-asmn)

Learn how to start ILUMYA® and find financial support for treating moderate-to-severe plaque psoriasis. See the full Prescribing Info and Medication Guide.See details»

Ilumya® - Coverage Information

Pr ILUMYA (tildrakizumab injection) is indicated for the treatment of adult patients with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. 10See details»

Details for: ILUMYA - Drug and Health Products Portal

Information on drug and health products authorized by Health Canada.See details»

Ilumya® - Vivo Infusion Therapy

Mar 21, 2018 Ilumya® Understanding Ilumya® Ilumya® (tildrakizumab-asmn) is a monoclonal antibody therapy that targets interleukin-23 (IL-23), a key cytokine involved in inflammatory and autoimmune diseases. It is used to treat โ€ฆSee details»

ILUMYA Injection Therapy | FlexCare Infusion Centers

ILUMYA injection therapy is an FDA-approved brand-name prescription medication for adults with moderate to severe plaque psoriasis. ILUMYA injection therapy is available at a FlexCare infusion clinic near you.See details»

Plaque Psoriasis Patient Resources | ILUMYA® (tildrakizumab-asmn)

Explore ILUMYA® resources including a discussion guide, plaque psoriasis information, and patient videos. See the full Prescribing Info and Medication Guide.See details»

PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION โ€ฆ

Immune Hypersensitivity ia occurred in Ilumya treated subjects in clinical trials. If a serious hypersensitivity reaction occurs, administration of Ilumya should be ns including Ilumya, there โ€ฆSee details»

ILUMYA® (tildrakizumab-asmn) Full Prescribing Information and ...

ILUMYA is an interleukin-23 antagonist indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. (1)See details»

ILUMYA - Optimum Care Partners

ILUMYA Injection Therapy Download Referral Form ILUMYA injection therapy is an FDA-approved brand-name prescription medication for adults with moderate to severe plaque โ€ฆSee details»

Ilumya® - Vivo Infusion

Mar 21, 2018 Ilumya® Understanding Ilumya® Ilumya® (tildrakizumab-asmn) is a monoclonal antibody therapy that targets interleukin-23 (IL-23), a key cytokine involved in inflammatory โ€ฆSee details»

ILUMYA® FAQs | ILUMYA® (tildrakizumab-asmn)

Find answers to common questions about biologic treatment for moderate-to-severe plaque psoriasis. See the full Prescribing Info and Medication Guide.See details»

Plaque Psoriasis Treatment | ILUMYA® (tildrakizumab-asmn)

ILUMYA tildrakizumab-asmn Injection 100 mg/ml- ILUMYA SUPPORT LIGHTING THE WAY@ DISCOVER SUPPORT THAT GETS YOU GOING AND KEEPS YOU GOING ILUMYA โ€ฆSee details»

ILUMY - Crunchbase Company Profile & Funding

ILUMY is a digital design and prototyping firm that creates websites, apps and platforms.See details»

ILUYMYA_WhatMattersMostInfographic_V21 - ILUMYA® โ€ฆ

ILUMYA® (tildrakizumab-asmn) is a prescription medicine used to treat adults with moderate to severe plaque psoriasis who may benefit from taking injections, pills (systemic therapy), or โ€ฆSee details»

PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION โ€ฆ

Ns including Ilumya, there is a potential for anaphylaxis. If an anaphylactic or other serious allergic reaction occurs, immediately discontinue the administr Inform patients/caregivers of the signs โ€ฆSee details»

FAQs | ILUMYA Copay Program

ILUMYA® Copay Program PO Box 2355 Morristown, NJ 07962 If the patient has already paid in full for ILUMYA ®, they can be reimbursed via check. The patient will need to submit a โ€ฆSee details»

illumy - The Hyper-Communication Platform of the Future

Introduction illumy is a new way to communicate with your friends, family, and colleagues. You can use illumy to send and receive emails, chat messages, voice calls, and video callsโ€”all in โ€ฆSee details»

Dosing With ILUMYA® | ILUMYA® (tildrakizumab-asmn)

With only 4 doses a year after 2 starter doses. Discover more about ILUMYA®. See the full Prescribing Info and Medication Guide.See details»

linkstock.net © 2022. All rights reserved